Pulmonary embolism causes: Difference between revisions
No edit summary |
Rabin Bista (talk | contribs) |
||
Line 43: | Line 43: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Asparaginase Erwinia Chrysanthemi]],[[Axitinib]], [[Bevacizumab]], [[Clomifene]], [[Crizotinib]], [[Desogestrel and Ethinyl Estradiol]], [[Epirubicin ]], [[Ethynodiol diacetate and ethinyl estradiol]], [[Etonogestrel]], [[glucocorticoids]], [[Goserelin]], [[hormone replacement therapy]], [[Interferon gamma]], [[lenalidomide]], [[Letrozole]], [[Medroxyprogesterone]], [[Meropenem]], [[Ospemifene]], [[Palbociclib]], [[Pergolide]], [[Polidocanol]], [[Pramipexole]], [[Progesterone]], [[oral contraceptives]], [[Romidepsin]], [[tamoxifen]], [[testosterone]], [[thalidomide]], [[Toremifene]], [[transdermal contraceptive]], [[Vorinostat]] | |bgcolor="Beige"| [[Asparaginase Erwinia Chrysanthemi]],[[Axitinib]], [[Bevacizumab]], [[Clomifene]], [[Crizotinib]], [[Desogestrel and Ethinyl Estradiol]], [[Epirubicin ]], [[Ethynodiol diacetate and ethinyl estradiol]], [[Etonogestrel]], [[glucocorticoids]], [[Goserelin]], [[hormone replacement therapy]], [[Idursulfase]], [[Interferon gamma]], [[lenalidomide]], [[Letrozole]], [[Medroxyprogesterone]], [[Meropenem]], [[Ospemifene]], [[Palbociclib]], [[Pergolide]], [[Polidocanol]], [[Pramipexole]], [[Progesterone]], [[oral contraceptives]], [[Romidepsin]], [[tamoxifen]], [[testosterone]], [[thalidomide]], [[Toremifene]], [[transdermal contraceptive]], [[Vorinostat]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" |
Revision as of 17:15, 23 February 2015
Resident Survival Guide |
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism causes On the Web |
Risk calculators and risk factors for Pulmonary embolism causes |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ogheneochuko Ajari, MB.BS, MS [3]
Overview
Pulmonary embolism (PE) is the acute obstruction of the pulmonary artery or one of its branches by a thrombus, air, tumor, or fat. Most often, PE is due to a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities, a process referred to as venous thromboembolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary embolism is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
- The most common cause of PE is a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities.
- Non-thrombotic causes of PE are: